Hydroxyurea synchronization increases mitotic yield in human glioma cell lines.

Area of Science:

• Oncology
• Cell Biology
• Genetics

Background:

• Karyotypic studies of human gliomas face challenges due to low mitotic index and poor chromosome banding.
• Accurate chromosomal analysis is crucial for understanding glioma development and progression.

Purpose of the Study:

• To evaluate hydroxyurea (HU) as a cell cycle synchronizing agent for human glioma cell lines.
• To improve chromosome preparation quality for diagnostic and research purposes.

Main Methods:

• Established human glioma cell lines (U-251MG, D-245MG, D-247MG, D-263MG) were treated with hydroxyurea (HU).
• Cell cycle progression and replication inhibition were assessed using flow cytometry based on DNA content.
• Mitotic index and cell populations in G2/M phases were quantified.

Main Results:

• Hydroxyurea demonstrated reversible inhibition of cellular replication in all tested glioma cell lines.
• HU treatment resulted in a two-to sixfold increase in the mitotic index.
• A higher percentage of cells were observed in the G2/M phases of the cell cycle following HU treatment.

Conclusions:

• Hydroxyurea is an effective agent for synchronizing human glioma cells.
• HU enhances chromosome preparation quality in short-term cultures from human tumor biopsies.
• This technique holds promise for improving cytogenetic analysis in neuro-oncology.